| Literature DB >> 33154655 |
Gemechu Ameya1, Temesgen Weldemedhin2, Tsegaye Tsalla3, Feleke Gebremeskel4.
Abstract
BACKGROUND: Septicemia is one of the major causes of morbidity and mortality in pediatric patients throughout the world. Drug-resistant pathogens are one of the major challenges to control. The study aimed to identify the major etiological agents, antimicrobial susceptibility pattern and associated factors of septicemia among pediatric patients in southern Ethiopia.Entities:
Keywords: antimicrobial susceptibility; multi-drug resistance; pediatric; septicemia
Year: 2020 PMID: 33154655 PMCID: PMC7608546 DOI: 10.2147/IDR.S278293
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Socio-Demographic & Socio-Economic Characteristics of Study Participants and Their Care Givers
| Variables | Frequency | Percent (%) |
|---|---|---|
| Sex | ||
| Male | 118 | 49.6 |
| Female | 120 | 50.4 |
| Age (Year) | ||
| < 1 | 66 | 27.7 |
| 1–4 | 83 | 34.9 |
| 5–9 | 53 | 22.3 |
| 10–15 | 36 | 15.1 |
| Pediatric BMI | ||
| <18.5kg/m2 | 42 | 17.6 |
| 18.5–24.9kg/m2 | 188 | 79 |
| >25kg/m2 | 8 | 3.4 |
| Resident | ||
| Urban | 128 | 53.8 |
| Rural | 110 | 46.2 |
| Educational status of care givers | ||
| Illiterate | 69 | 29 |
| Primary education | 51 | 21.4 |
| Secondary education | 77 | 32.4 |
| Tertiary education | 41 | 17.2 |
| Occupational status care givers | ||
| Government employee | 46 | 19.3 |
| Farmer | 43 | 18.1 |
| Merchant | 41 | 17.2 |
| Daily labor | 40 | 16.8 |
| Private organizations | 40 | 16.8 |
| House servant | 17 | 7.2 |
| Others* | 11 | 4.6 |
| Family Size | ||
| ≤4 | 25 | 10.5 |
| 5–9 | 182 | 76.5 |
| ≥ 10 | 31 | 13 |
| Monthly Income of Parents (Birr) | ||
| < 1000 | 133 | 55.9 |
| ≥1000 | 105 | 44.1 |
Note: Other* includes House wife and Driver.
Clinical Characteristics of Study Participants
| Variables | Frequency | Percent |
|---|---|---|
| Hospital Admission | ||
| Yes | 85 | 35.7 |
| No | 153 | 64.3 |
| Admission Date | ||
| <10 | 64 | 75.3 |
| ≥10 | 21 | 24.7 |
| Medical Procedures Usage | ||
| Intravenous device | 61 | 25.6 |
| Endotracheal tube | 6 | 2.5 |
| Surgery | 4 | 1.7 |
| Prolonged antibiotic usage | ||
| Yes | 10 | 4.2 |
| No | 228 | 95.8 |
| Chronic Disease | ||
| HIV/AIDS | 6 | 2.5 |
| Others* | 9 | 3.8 |
| Clinical Diagnosis | ||
| Burns case | 23 | 9.7 |
| Respiratory disease | 47 | 19.7 |
| Febrile illness | 87 | 36.6 |
| Wound case | 17 | 7.1 |
| Urinary tract disease | 17 | 7.1 |
| Gastrointestinal disease | 21 | 8.8 |
| Skin disease | 16 | 6.7 |
| Others** | 11 | 4.1 |
Notes: Others* includes diabetes mellitus, chronic liver disease, chronic kidney disease and asthmatic patient; Others** includes skin disease, heart disease, generalized swelling.
Figure 1Distribution of bacterial species isolated in study participants.
Factors Associated with Pediatric Septicemia in Study Participants
| Variables | Positive N (%) | Negative N (%) | COR (95% CI) | AOR (95% CI) | P-value |
|---|---|---|---|---|---|
| Age | |||||
| 1–11 months | 17 (25.8) | 49 (74.2) | 4.80 (1.77, 12.99) | 4.18 (1.34, 13.00) | 0.014 |
| 1–4 years | 4 (4.8) | 79 (95.2) | 0.70 (0.19,2.58) | 0.68 (0.17, 2.78) | 0.591 |
| 5–15 years | 6 (6.7) | 83 (93.3) | Ref | Ref | Ref |
| Admission Date | |||||
| No admissions | 11 (7.2) | 142 (92.8) | Ref | Ref | Ref |
| ≤10 | 6 (9.4) | 58 (90.6) | 0.99 (0.34, 2.95) | 0.81 (0.24, 2.67) | 0.723 |
| >10 | 10 (47.6) | 11 (52.4) | 10.68 (3.78, 30.21) | 5.54 (1.51, 20.41) | 0.010 |
| Wound case | |||||
| Yes | 7 (41.2) | 10 (58.8) | 7.04 (2.41, 20.50) | 5.52 (1.50, 20.34) | 0.010 |
| No | 20 (9) | 201 (91.0) | Ref | Ref | Ref |
| Burn case | |||||
| Yes | 8 (34.8) | 15 (65.2) | 5.50 (2.07,14.64) | 3.55 (1.02, 12.38) | 0.047 |
| No | 19 (8.8) | 196 (91.2) | Ref | Ref | Ref |
| Usage of intravenous device | |||||
| Yes | 9 (14.8) | 52 (85.2) | 1.53 (0.65, 3.61) | 0.41 (0.09, 1.89) | 0.253 |
| No | 18 (10.2) | 159 (89.8) | Ref | Ref | Ref |
Abbreviations: COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval; Ref, reference.
Antimicrobial Susceptibility Pattern of Gram-Positive Bacteria Isolated from Study Participants
| Antibiotics | Total (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| S | I | R | S | I | R | S | I | R | |
| CTR | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 |
| AMC | 0 | 0 | 100 | 0 | 14.3 | 85.7 | 0 | 6.2 | 93.8 |
| AMP | 22.2 | 0 | 77.8 | 71.4 | 14.3 | 14.3 | 43.8 | 6.2 | 50 |
| DOX | 22.2 | 0 | 77.8 | 85.7 | 0 | 14.3 | 50 | 0 | 50 |
| CPR | 11.1 | 11.1 | 77.8 | 14.3 | 42.9 | 42.9 | 12.5 | 25 | 62.5 |
| CHL | 55.6 | 33.3 | 11.1 | 85.7 | 0 | 14.3 | 68.8 | 18.8 | 12.5 |
| CLT | 88.9 | 11.1 | 0 | 85.7 | 14.3 | 0 | 87.5 | 12.5 | 0 |
| K | 22.2 | 44.4 | 33.3 | 14.3 | 57.1 | 28.6 | 18.8 | 50 | 31.2 |
| TET | 22.2 | 0 | 77.8 | 57.1 | 0 | 42.9 | 37.5 | 0 | 62.5 |
| GEN | 44.4 | 22.2 | 33.3 | 42.9 | 28.6 | 28.6 | 43.8 | 25 | 31.2 |
| CXT | 77.8 | 0 | 22.2 | 85.7 | 0 | 14.3 | 81.2 | 0 | 18.8 |
| COT | 22.2 | 0 | 77.8 | 71.4 | 0 | 28.6 | 43.8 | 0 | 56.2 |
| ERY | 11.1 | 0 | 88.9 | 28.6 | 42.9 | 28.6 | 18.8 | 18.8 | 62.5 |
| PEN | 0 | 22.2 | 77.8 | 0 | 71.4 | 28.6 | 0 | 43.8 | 56.2 |
| AUG | 55.6 | 22.2 | 22.2 | 71.4 | 28.6 | 0 | 62.5 | 25 | 12.5 |
Abbreviations: CTR, ceftriaxone; AMC, amoxicillin; AMP, ampicillin; DOX, doxycycline; AUG, amoxicillin-clavulanic acid; CLT, cephalothin; CHL, chloramphenicol; CPR, ciprofloxacin; GEN, gentamicin; TET, tetracycline; K, kanamycin; PEN, penicillin; COT, trimethoprim-sulfamethoxazole; CXT, cefoxitin; ERY, erythromycin; S, sensitive; I, intermediate; R, resistance; MRSA, methicillin resistant Staphylococcus aureus; MSSA, methicillin sensitive Staphylococcus aureus.
Antimicrobial Susceptibility Pattern of Gram Negative Bacteria Isolated from Study Participants
| Bacteria Isolates (%) | Antibacterial Drugs | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTR | AMC | AMP | DOX | CPR | CHL | CLT | TET | GEN | COT | STR | AUG | ||
| S | 0 | 0 | 0 | 50 | 75 | 0 | 0 | 75 | 0 | 100 | 0 | 0 | |
| I | 50 | 0 | 0 | 25 | 25 | 75 | 0 | 0 | 50 | 0 | 0 | 0 | |
| R | 50 | 100 | 100 | 25 | 0 | 25 | 100 | 25 | 50 | 0 | 100 | 100 | |
| S | 0 | 0 | 0 | 100 | 100 | 66.7 | 0 | 66.7 | 0 | 100 | 0 | 0 | |
| I | 33.3 | 0 | 0 | 0 | 0 | 33.3 | 0 | 33.3 | 0 | 0 | 0 | 0 | |
| R | 66.7 | 100 | 100 | 0 | 0 | 0 | 100 | 0 | 100 | 0 | 100 | 100 | |
| S | 100 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 100 | 0 | 100 | |
| I | 0 | 0 | 50 | 0 | 0 | 0 | 50 | 0 | 50 | 0 | 0 | 0 | |
| R | 0 | 100 | 50 | 100 | 0 | 0 | 50 | 100 | 50 | 0 | 100 | 0 | |
| S | 50 | 0 | 0 | 100 | 100 | 100 | 0 | 100 | 0 | 100 | 0 | 100 | |
| I | 50 | 0 | 50 | 0 | 0 | 0 | 50 | 0 | 0 | 0 | 0 | 0 | |
| R | 0 | 100 | 50 | 0 | 0 | 0 | 50 | 0 | 100 | 0 | 100 | 0 | |
| S | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | |
| I | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| R | 100 | 100 | 100 | 0 | 0 | 100 | 100 | 100 | 0 | 100 | 100 | 100 | |
| Total | S | 25 | 0 | 0 | 58.3 | 83.3 | 50 | 0 | 58.3 | 8.3 | 91.7 | 0 | 33.3 |
| I | 33.3 | 0 | 16.7 | 16.7 | 16.7 | 33.3 | 16.7 | 8.3 | 25 | 0 | 0 | 0 | |
| R | 41.7 | 100 | 83.3 | 25 | 0 | 16.7 | 83.3 | 33.3 | 66.7 | 8.3 | 100 | 66.7 | |
Abbreviations: CTR, ceftriaxone; AMC, amoxicillin; AMP, ampicillin; DOX, doxycycline; AUG, amoxicillin-clavulanic acid; CLT, cephalothin; CHL, chloramphenicol; CPR, ciprofloxacin; GEN, gentamicin; TET, tetracycline; COT, trimethoprim-sulfamethoxazole; STR, streptomycin; S, sensitive; I, intermediate; R, resistance.
Figure 2Multi-drug resistance isolates among identified bacteria from blood sample.